Navigation Links
Amsterdam Molecular Therapeutics to Appoint George Morstyn to Supervisory Board
Date:4/2/2008

AMSTERDAM, The Netherlands, April 2 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that AMT's Supervisory Board has decided to propose Dr. George Morstyn to be appointed to the Supervisory Board at its Annual General Meeting of shareholders on April 16, 2008. Dr. Morstyn (MB BS PhD FRACP), who retired as Senior Vice President of Development at Amgen, was a member of Amgen's executive committee and responsible for global preclinical and clinical development as well as regulatory affairs.

Dr. Morstyn also played an active role in representing Amgen to the financial community. Five new drugs and many label extensions were approved during his 11 year tenure. Dr. Morstyn graduated from Monash University, completed a Ph.D. with Professor Donald Metcalf at the Walter and Eliza Hall Institute and trained in medical oncology at the National Cancer Institute in the US. He was Head of the Clinical Program of the Ludwig Institute for Cancer Research in Melbourne for eight years. Dr. Morstyn was an early clinical investigator of several biological agents prior to joining Amgen, and performed seminal work on the development of G-CSF, which later became Neupogen, Amgen's second blockbuster drug. Dr. Morstyn is currently a board member of several Australian biotechnology companies.

Further to a plan of rotation, AMT aims to build a fully independent Supervisory Board in the course of 2008. Earlier this year, AMT announced the nominations of Alexander Ribbink, COO of TomTom, and Philippe van Holle, Head of Celgene Europe, to its Supervisory Board.

AMT's AGM is scheduled for April 16, 10:30 a.m., and will take place at the Rosarium, Amsterdam, The Netherlands.

About Amsterdam Molecular Therapeutics

AMT has a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have prevented gene therapy from becoming a ma
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Amsterdam Molecular Therapeutics to Appoint Alexander Ribbink to Supervisory Board
2. Amsterdam Molecular Therapeutics Reports Full Year Results 2007
3. Amsterdam Molecular Therapeutics to Appoint Philippe van Holle (Celgene) to Supervisory Board
4. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Sigma-Aldrich Partners With Sunset Molecular Discovery to Expand Your Favorite Gene Search Tool
7. Vicus Therapeutics Announces Participation at 15th International Molecular Medicine Tri-Conference
8. Society for Biomolecular Sciences Announces 2008 Conference Speaker Line-up
9. WaferGen to Present at the Cambridge Health Institutes Fifth Annual Molecular Diagnostics Partnerships in Personalized Medicine Conference
10. NIST team proves bridge from conventional to molecular electronics possible
11. AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... CA (PRWEB) May 05, 2015 ... Life Science Animal Health, Jeffrey Schaffer, DVM, as ... “With over 15 years of experience in the ... a great addition to our veterinarian lead organization”. ... Officer, explains. “Dr. Schaffer will be responsible for ...
(Date:5/5/2015)... IN (PRWEB) May 05, 2015 The ... the state of Indiana, led by Indiana Gov. Mike ... Day. The AMA Foundation will host a Family Fest ... celebration. All proceeds will benefit the Wounded Warrior Project. ... the Academy of Model Aeronautics—the country’s foremost organization for ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 A comment ... a wide range of key photonics technologies – regulations ... competitiveness of U.S. industry. To help the community understand ... 12 May on the proposed changes to U.S. ... covered by International Traffic in Arms Regulations (ITAR). , ...
(Date:5/5/2015)... 5, 2015  Orexigen Therapeutics, Inc. (Nasdaq: OREX ... 2015 on Friday, May 8 before the market opens. ... and conference call at 8:30 a.m. Eastern Time (5:30 ... be accessed by phone by calling (800) 708-4540 (domestic) ... can be accessed live on the Investors section of ...
Breaking Biology Technology:Leading Regenerative Veterinary Medicine Company, VetStem Biopharma announces the addition of Dr Jeffrey Schaffer as the Director of Veterinary Professional Services. 2State of Indiana proclaims August 15 as Model Aviation Day 2Comments needed now from photonics industry on revisions of U.S. export rules 2Comments needed now from photonics industry on revisions of U.S. export rules 3Comments needed now from photonics industry on revisions of U.S. export rules 4
... Sciences, LLC (IDS),with its strategic science partner the Idaho ... Award for AbP ID(TM), a new groundbreaking,forensic human identification ... labs in late 2009 or early 2010, will be ... accurate, reliable results in as,little as two hours., ...
... Orexigen(R) Therapeutics,Inc. (Nasdaq: OREX ), a biopharmaceutical ... nervous system-related disorders, today,announced that Dr. Dennis Kim has ... Obesity and Metabolic Disorders. Dr. Kim will be,leading the ... am thrilled to be joining the team at Orexigen ...
... 3 Data Offers Additional,Information on Bazedoxifene Alone, ... retrospective analysis of,Phase 3 two-year data presented ... American,Menopause Society (NAMS) suggest that postmenopausal women ... of,breast tenderness and abnormal mammograms no greater ...
Cached Biology Technology:New, Fast Forensic Technology Wins R&D 100 Award 2Orexigen(R) Therapeutics Appoints Dennis Kim, M.D., as Senior Vice President, Head of Obesity and Metabolic Disorders 2Retrospective Analysis of Phase 3 Data Suggest Wyeth's Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms 2Retrospective Analysis of Phase 3 Data Suggest Wyeth's Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms 3Retrospective Analysis of Phase 3 Data Suggest Wyeth's Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms 4
(Date:4/13/2015)... , April 13, 2015  higi, a leading cloud-based ... to more fully engage with their communities around health ... privacy protected and secure API.  ... the most accessible, affordable, and convenient vehicle to receive ... The API will allow higi,s ...
(Date:4/8/2015)... 2015  Infinisource, a leading provider of SaaS-based Human ... a leading supplier of biometric identification and security ... most advanced biometrically-enabled time clock, the companies announced ... is setting a bold, new standard for the ... small and mid-size employer. When connected to the ...
(Date:4/2/2015)... 2, 2015 At its 2015 ACMG Annual ... , the American College of Medical Genetics and ... to its Board.  Members of the ACMG Board of ... forming and advancing its policies and programs. ACMG is ... "It,s an eventful time in medical genetics and ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
... ORLANDO, Nov. 6 Downing an energy drink may ... in a small study presented at the American Heart ... Wayne State University researchers, blood pressure and heart rate ... a day of a popular energy drink., While the ...
... has published a new analysis showing that as plant species ... and contain fewer total plants a situation that could ... The article is to appear in the online ... the week of Nov. 5. The process by which ...
... today its involvement in an expanded access program ... for phenylketonuria (PKU), a rare genetic metabolic disorder ... can result in severe mental retardation. Currently, there ... program at Nationwide Childrens. Under an expanded ...
Cached Biology News:Energy drinks may pose risks for people with high blood pressure, heart disease 2Energy drinks may pose risks for people with high blood pressure, heart disease 3Scientists warn that species extinction could reduce productivity of plants on Earth by half 2Nationwide Children's Hospital involved in expanded access program for treatment of PKU 2
... liquid handling system from Molecular Devices provides ... one instrument. The system handles a variety ... washing96-, 384- and 1536-welland is the first ... has been optimized to dispense from four ...
... Plate consists of an anodized aluminum body ... Fluorescent Compounds embedded in polymerized matrix. It ... FLx800 and Synergy Multi-Detection Readers. This multi-functional ... while reducing the need for tedious wet ...
... the SMZ line is a Greenough stereomicroscope designed ... It is available with a choice of a ... compact base (N2GG). This microscope can be easily ... all at the same time giving you ultimate ...
... for siRNA applications, contains magnetic nanoparticles (MagTag) ... acid of interest. Exploiting magnetic force the ... drawn towards and delivered into the target ... can be used for adherent cells; for ...
Biology Products: